News and Events

Cellomatics BioSciences announces the inclusion of NanoEnTek’s JuLITM Stage real-time qualitative and quantitative live-cell imaging technology to support client’s discovery projects.

Biocity Nottingham, UK

Cellomatics BioSciences Limited, a specialised preclinical laboratory CRO, announces the inclusion of NanoEnTek’s JuLI Stage real-time qualitative and quantitative live-cell imaging technology to its repertoire.

Cellomatics BioSciences is continually striving to offer added value to all our client discovery projects. We achieve this by constantly reviewing and e...

Cellomatics BioSciences will be attending the 3rd World Preclinical Congress Europe

Lisbon, Portugal 27th to 30th November 2018.

Cellomatics BioSciences will be attending the 3rd World Preclinical Congress to be held in Lisbon, Portugal from 27th to 30th November. To arrange meetings please get in touch with us by emailing to info@cellomaticsbio.com




...

Cellomatics BioSciences secures University of Derby's Invest to Grow Grant funding

119-122 Stewart Adams Building, Biocity, Pennyfoot Street, Nottingham NG1 1GF

Cellomatics BioSciences Ltd. is delighted and pleased to announce that we (www.cellomaticsbio.com) have been offered a grant funding from University of Derbys Invest to Grow Fund.

We are constantly striving to add more value to the services offered to our Sponsors. Thanks to the funding support from University of Derbys Invest to ...

Cellomatics BioSciences celebratins it's 3-year journey

119-122 Stewart Adams Building, Biocity, Pennyfoot Street, Nottingham NG1 1GF

Cellomatics BioSciences Ltd is celebrating the completion of its third year in business today. This is a significant milestone in our journey. I would therefore like to take this opportunity to thank my Staff and all our Clients, Partners, Colleagues, Family and Friends for being part of our Growth and Success. We have built great relationships and are now looking forward to streng...

Cellomatics BioSciences Ltd will be moving to a new facility

119-122 Stewart Adams Building, Biocity, Pennyfoot Street, Nottingham NG1 1GF.

Extremely proud to announce that as of 1st Feb 2018, we will be moving to our new state-of-the-art facility at 119-122 Stewart Adams Building, Biocity, Pennyfoot Street, Nottingham NG1 1GF.

The new facility will accommodate the growing business and provide needed additional space for the company’s diversified portfolio of preclinical in vitro servic...

Cellomatics BioSciences Ltd collaborates with Krisani Bioscience to advance development of a prodrug compound for the treatment of Nephropathic Cystinosis

Media Release

Cellomatics BioSciences Ltd (www.cellomaticsbio.com) announced its collaboration with Krisani Biosciences (www.krisanibio.com) to advance a novel molecular prodrug conjugate of cysteamine and eicosapentaenoic acid (EPA) for the therapeutic management of nephropa...

Cellomatics Biosciences will be attending OnHelix translational research conference for the life science sector

13th July 2017; Wellcome Genome Campus Conference Centre, Hinxton   

Cellomatics BioSciences will be attending OnHelix (http://www.onhelix.com/), a translational research conference for the life science sector, on the 13th July 2017.
For partnering, please contact us at bd@cellomaticsbio.com

Read more

Cellomatics BioSciences will be attending BioTrinity, London

London, May 08-10 2017

Cellomatics BioSciences will be attending #BioTrinity London, May 08-10 2017. We are specialists in providing #pre-clinic...

LATi 2016 Bioscience Showcase at BioCity Nottingham

Cellomatics Bioscience attended the LATi 2016 Bioscience Showcase at BioCity Nottingham this week. Based on the theme ‘building and sustaining a bioscience business in the life sciences sector’ the event encompassed numerous informative talks from experienced individuals in the sector as well as a networking event involving an exhibition and showcase from useful companies in the region. This ...